Trials / Completed
CompletedNCT03078023
Sponge and Eosinophil Peroxidase (EPO) Staining
Is EPO Staining on Esophageal Sponge Samples a Simple Reliable Method of Accessing Esophageal Eosinophilia?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Are we able to use the EPO staining technique using the sponge ?
Detailed description
EPO staining on esophageal sponge samples had a strong association with peak esophageal eosinophil counts on endoscopic biopsy specimens in a small study of 26 patients Using a cut-off of 1.1 absorbance units in a colorimetric assay at a wavelength of 492nm the EPO stain had sensitivity and specificity of 1105 and 83% respectively for a peak eosinophil count of 15 eos/hpf on histologic endoscopic obtained biopsy specimens. The technique of EPO staining is standardized and can be completed in 45 minutes time. Currently, we have found esophageal sponge cytology sensitive and specific for assessment of esophageal eosinophilia. It allows disease activity assessment without endoscopy is much preferred by patients over the standard endoscopic technique of disease assessment. The process of specimen preparation in fairly tedious and interpretation takes significant experience. If EPO staining on non-endoscopic esophageal sponge studies was accurate at assessing disease activity, this is a tool that could be easily performed and interpreted with a rapid turnaround time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | swallowed sponge device | Swallowed sponge: Subjects having a clinical upper endoscopy will be asked to swallow the sponge 2 hours prior to EGD |
Timeline
- Start date
- 2017-03-08
- Primary completion
- 2019-07-19
- Completion
- 2019-07-19
- First posted
- 2017-03-13
- Last updated
- 2022-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03078023. Inclusion in this directory is not an endorsement.